• Caplin Point
    Providing remedies
    BRINGING SMILES to people
  • We Choose To Be
  • We always took
    the road less travelled and
    that has made ALL THE DIFFERENCE



Caplin Point Laboratories Ltd Unit-I (CP-I) is a WHO-GMP approved facility, situated in Suthukeny, which is about 20 km from Puducherry.

The company has the facilities to manufacture :
  • Sterile Penem Injectables
  • Tablets
  • Capsules
  • Liquid Orals (Syrup & Suspension)
  • Soft Gelatin Capsules
  • Dry powder for Oral Suspension
  • Suppositories and Ovules

Location : Suthukeny, Puducherry


Caplin Point has set up a dedicated pharmaceutical R&D facility with capabilities to develop safe and effective formulations. Sophisticated facilities and resources are available to develop dosage forms like Tablets, Capsules, Semi-solids (including suppositories), Liquid orals, Granules and Soft Geltin Capsules. The R & D facility is having separate teams for formulation development and analytical development. R & D scale stability studies, forced degradation studies, method development and validations are carried out in-house.

The following range of services are provided :
  • Design and development of new dosage forms as per customer needs
  • Process improvements and optimization
  • Stability studies as per ICH guidelines
  • Analytical development and Method validations as per ICH
  • Technology transfer of new developed formulations
  • Dissolution profiles as per CDER/EU guidelines

Location : Gummidipoondi, Chennai

CP-III / Argus

Caplin Point Laboratories Ltd Unit-III (Argus) is situated in the foothills town of Baddi in Himachal Pradesh with a panoramic view on Pinjore Nalagarh highway.

CP-III has the modern machinery to manufacture the topical formulations such as Ointments, Creams, Gels, Lotions and Capsules.

Location : Baddi, Himachal Pradesh


Caplin Point Laboratories Limited, Unit – IV (CP-IV) is a US FDA, EU-GMP, ANVISA and INVIMA approved manufacturing facility handling Pharmaceutical formulations in Specialized Injectable dosage forms and Ophthalmic drops. The facility is designed with a high level of sophistication and automated process control and is in compliance with norms stated by US FDA, UK MHRA and other regulatory bodies belonging to PIC/s.

The Site has a dedicated facility for formulation development, analytical development and stability department for product development in sterile dosage forms.

CP-IV is capable of handling general category and specialized category injectable dosages in Vial, Ampoules, Lyophilized Vials and Ophthalmic dosages.

The plant capacity is :
  • Ampoules : 25 Million units per annum
  • Vial : 25 Million units per annum
  • Lyophilized Vials : 1.2 Million units per annum
  • Ophthalmics : 12 Million units per annum

Location : Gummidipoondi, Chennai


Caplin Point has 2 DSIR approved dedicated R&D setups with capabilities to develop safe and effective formulations. Caplin Point has a team of over 80+ scientists working on development of varied dosage forms such as Injectables, Soft Gelatin Capsules, Suppositories, Tablets, Capsules, Semi-solids and Liquid orals.

Separate teams work on formulation development and analytical studies of molecules for Regulated and Emerging markets. R & D scale stability studies, forced degradation studies, method development and validations are carried out in house. The Caplin R&D teams continue to grow in strength each year, taking on complex challenges across varied formulations.


Caplin Point is headquartered in the Southern Indian city of Chennai, with close access to its manufacturing units and the Chennai seaport. Corporate team of 140+ personnel handle various areas from Finance, Administration, Regulatory, HR, PPIC, Supply Chain and Corporate QA from Chennai.

Caplin Point has branches and subsidiaries established in China and Hong Kong, and is in the process of establishing more subsidiaries in Colombia and other locations, as part of its expansion strategy.